April 29 run/walk to raise funds for lung cancer research
WASHINGTON, March 29, 2012 /PRNewswire-USNewswire/ -- LUNGevity Foundation has teamed with the Thomas G. Labrecque Foundation to present the ninth annual "Run as One" event in New York City's Central Park on Sunday, April 29, 2012.
LUNGevity is the nation's largest lung cancer-focused nonprofit, and the Thomas G. Labrecque Foundation is a leading supporter of lung cancer research and awareness. The Foundations recently announced they are joining together to host a series of fundraising and lung cancer awareness events, kicking off with the 9th annual "Run as One" event. The two organizations will also sponsor Run as One teams for the 2012 Marine Corps Marathon and the 2012 ING New York City Marathon.
A qualifying event for the ING NYC Marathon, the 4-mile "Run as One" event is more than a cause race, attracting elite runners as well as recreational enthusiasts. "Run as One" also includes a 1.3-mile walk so families and participants of all ages can enjoy the event together. The race and walk will be followed by a festival at Rumsey Playground.
The popular race was launched by the Thomas G. Labrecque Foundation in 2003, and annually attracts as many as 10,000 runners and walkers as it calls attention to the fight against lung cancer.
To learn more and to register, go to www.lungevity.org/runasone.
WHAT: "Run as One" Run and Walk Event
WHEN: April 29, 2012
Registration/Bib Pick-Up Opens: 6:30 a.m.
4-Mile Timed Run: 9:00 a.m.
1.3 Mile Walk: 9:15 a.m.
Post-Race Awards and Remarks: 10:15 a.m.
COST: 4-Mile Timed Runner: $25
1.3 Mile Untimed Walker: $25
WHERE: Central Park
New York, NY
For more information: To learn more and to register, go to: www.lungevity.org/runasone
Questions pertaining to participating in the event or sponsorships should be directed to: firstname.lastname@example.org
About LUNGevity Foundation
The mission of LUNGevity Foundation is to have a meaningful impact on improving lung cancer survival rates, ensure a higher quality of life for lung cancer patients, and provide a community for those impacted by lung cancer.
Through the support of critical research into the early detection and successful treatment of lung cancer, as well as providing information, resources and a community to patients and caregivers, LUNGevity is creating and sharing hope for cures, treatments and enhanced quality of life for lung cancer patients.
LUNGevity seeks to inspire the nation to commit to ending lung cancer.
For more information, please visit www.lungevity.org.
About Thomas G. Labrecque Foundation
The Thomas G. Labrecque Foundation is committed to preventing lung cancer through education and research. At the age of 62, Tom Labrecque, the former Chairman of The Chase Manhattan Bank, a never-smoker, died from lung cancer eight weeks after being diagnosed. Tom's family and friends started the Thomas G. Labrecque Foundation in 2002 to fight the #1 cancer killer in the United States. The Foundation has a two-pronged mission, to fund effective research and to educate people about lung cancer. In the process we want to break some of the stigmas associated with the disease, since many people believe it is a smoker's disease. For more information about the Thomas G. Labrecque Foundation, please visit www.tglfoundation.com.
About Lung Cancer
- 1 in 14 Americans is diagnosed with lung cancer in their lifetime
- Lung cancer is the leading cause of cancer death, regardless of gender or ethnicity
- Lung cancer kills almost twice as many women as breast cancer and more than three times as many men as prostate cancer
- About 55% of all new lung cancer diagnoses are among people who have never smoked or are former smokers
- Only 16% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it's caught before it spreads, the chance for 5-year survival improves to 52%
SOURCE LUNGevity Foundation